An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of Dyslipidemia

NCT05120895 · clinicaltrials.gov ↗

COMPLETED

Status

3060

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Mevalotin

Sponsor

Daiichi Sankyo

Collaborators

[object Object]